Clinical trial EMERALD
Elacestrant Monotherapy for the Treatment of ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-Label, Active-Controlled, Multicenter Trial
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | Radius Health, Inc |
| EudraCT Identifier | 2018-002990-24 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03778931 |
| Inclusion criteria | ESR1-mut or ESR1-WT |
| Last update |